MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 60 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |